C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
2.530
-0.120 (-4.53%)
At close: Nov 17, 2026, 4:00 PM EST
2.520
-0.010 (-0.40%)
After-hours: Nov 17, 2026, 7:41 PM EST
C4 Therapeutics Market Cap
C4 Therapeutics has a market cap or net worth of $332.23 million as of November 17, 2026. It is the 16,978th most valuable company in the world and the 3,024th biggest in the United States. Its market cap has increased by 38.79% in one year.
Market Cap
332.23M
Enterprise Value
112.79M
1-Year Change
38.79%
Global Rank
Country Rank
#3,024 United States
Category
ChartMarket Cap Chart
Since the IPO on October 2, 2020, C4 Therapeutics's market cap has decreased from $772.72M to $332.23M, a decrease of -57.00%. That is a compound annual growth rate of -12.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 332.23M | 79.48% |
| Dec 31, 2025 | 185.11M | -27.16% |
| Dec 31, 2024 | 254.12M | -8.73% |
| Dec 29, 2023 | 278.44M | -3.60% |
| Dec 30, 2022 | 288.85M | -81.55% |
| Dec 31, 2021 | 1.57B | 9.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CorMedix | 383.37M |
| Alector | 382.61M |
| Contineum Therapeutics | 379.70M |
| Puma Biotechnology | 379.47M |
| Rezolute | 375.55M |
| ARS Pharmaceuticals | 360.90M |
| Lyell Immunopharma | 360.18M |
| Aspen Neuroscience | 355.63M |